ClinConnect ClinConnect Logo
Search / Trial NCT06729983

Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty Outcomes

Launched by NICKOLAS GARBIS · Dec 9, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Reverse Shoulder Athroplasty Conjoint Tendon Lengthening Pain Outcome

ClinConnect Summary

This clinical trial is studying a surgical technique called conjoint tendon lengthening, which may help prevent or reduce shoulder pain after a procedure known as reverse shoulder arthroplasty (a type of shoulder replacement surgery). Some patients experience pain at the front of their shoulder after this surgery, possibly due to changes in how the shoulder joint aligns. By cutting and lengthening the conjoint tendon, the hope is to relieve the tension and pressure that can cause this pain.

To participate in this trial, you need to be at least 18 years old and scheduled for your first reverse shoulder replacement surgery at one of the participating hospitals in Illinois. Unfortunately, if you are pregnant, have had certain prior surgeries on your shoulder, or are under 18, you won't be eligible. If you join the trial, you will receive the standard care for your surgery, along with the potential benefits of the tendon lengthening procedure. The study aims to see if this technique makes a difference in reducing shoulder pain one year after surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who are at least 18 years old undergoing primary reverse total shoulder arthroplasty
  • Operations that occur at Loyola University Medical Center (Maywood, IL), Loyola Ambulatory Surgery Center (Maywood, IL), or Gottlieb Memorial Hospital
  • Exclusion Criteria:
  • Patients younger than 18 years old
  • Patients who had prior coracoid transfer procedure
  • Patients who are undergoing revision surgery from a prior arthroplasty
  • Current pregnancy As per standard protocol with all surgeries, a urine pregnancy test is performed prior to surgery. If positive, the surgery will be cancelled and the patient will be excluded from the research study.

About Nickolas Garbis

Nickolas Garbis is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in managing and overseeing clinical studies, he focuses on innovative therapies and cutting-edge treatments across various therapeutic areas. Nickolas is recognized for his strategic approach to trial design, regulatory compliance, and patient recruitment, ensuring that studies are conducted efficiently and ethically. His passion for enhancing healthcare drives his collaborative efforts with researchers, institutions, and stakeholders, fostering an environment of innovation and excellence in clinical research.

Locations

Maywood, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Nickolas G Garbis, MD

Principal Investigator

Loyola University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported